Syneron Medical Earnings: Here’s Why Shares are Up Now
Syneron Medical Ltd. (NASDAQ:ELOS) delivered a profit and beat Wall Street’s expectations, AND beat the revenue expectation. The revenue beat is a positive sign to shareholders seeking high growth out of the company. Shares are up 3%.
Syneron Medical Ltd. Earnings Cheat Sheet
Results: Adjusted Earnings Per Share increased 266.67% to $0.11 in the quarter versus EPS of $-0.14 in the year-earlier quarter.
Revenue: Rose 19.32% to $72.8 million from the year-earlier quarter.
Actual vs. Wall St. Expectations: Syneron Medical Ltd. reported adjusted EPS income of $0.11 per share. By that measure, the company beat the mean analyst estimate of $0.09. It beat the average revenue estimate of $70.6 million.
Quoting Management: Louis P. Scafuri, Chief Executive Officer of Syneron, commented, “We finished the year with a strong fourth quarter with record revenues. The PAD segment delivered robust revenue growth combined with enhanced operating leverage. Our network of subsidiaries and distribution partners contributed to solid international results, including strong performance in Asia. In North America, our team had particular success with the elos Plus™ next generation multi-platform system and GentleMax Pro® multi-wavelength system, providing positive initial signs that our sales force restructuring strategy is on track. We also continued to roll out UltraShape in international markets and drive enrollment in the U.S. clinical trial. We remain on track for potential FDA clearance by the end of 2013.
Key Stats (on next page)…
Revenue increased 21.07% from $60.13 million in the previous quarter. EPS increased 266.67% from $0.03 in the previous quarter.
Looking Forward: Analysts have a neutral outlook for the company’s next-quarter performance. Over the past three months, the average estimate for next quarter’s earnings is a profit of $0.12 and has not changed. For the current year, the average estimate has moved down from a profit of $0.21 to a profit of $0.19 over the last ninety days.
Stocks with improving earnings metrics are worthy of your extra attention. In fact, “E = Earnings Are Increasing Quarter-Over-Quarter” is a core component of our CHEAT SHEET investing framework for this very reason. Don’t waste another minute – click here and get our CHEAT SHEET stock picks now.
(Company fundamentals provided by Xignite Financials. Email any earnings discrepancies to earnings [at] wallstcheatsheet.com)